Miami-based RapidPulse Secures $48 Million in Latest Series B Funding Round

Miami-based RapidPulse secured $48 million in its latest Series B, adding another data point to the Enterprise Software & SaaS funding market.

Miami-based RapidPulse Raises $48 million in Funding

Miami-based RapidPulse secures $48M Series B co-led by Medtronic to transform stroke treatment. Miami-based RapidPulse develops next-generation aspiration technology for treating acute ischemic stroke.

Investors Behind the Funding

The round was backed by Medtronic. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Miami-based RapidPulse operates in Enterprise Software & SaaS. Miami-based RapidPulse's financing adds to recent private-market activity.

Strategic Use of Funds

transform stroke treatment

Looking Ahead

This financing enables us to complete the TURBO study, expand clinical experience across leading stroke centers, and data permitting, seek FDA approval for the RapidPulse system,

Source reference: original announcement/article.